SPHERA FUNDS MANAGEMENT LTD.

CIK: 0001496201Latest portfolio: $517.3M · Q4 2025

Holdings

98

Total Value

$517.3M

New Positions

24

Closed Positions

31

#StockSharesValue% PortfolioChangeType
1
TEVATEVA PHARMACEUTICAL INDS LTD
1,123,525$35.1M6.78%-383,500
2
BIIBBIOGEN INC
94,738$16.7M3.22%+12K
3
MLYSMINERALYS THERAPEUTICS INC
449,003$16.3M3.15%+229K
4
SNDXSYNDAX PHARMACEUTICALS INC
762,563$16.0M3.10%+375K
5
NVMINOVA LTD
47,846$15.7M3.04%+4K
6
RAREULTRAGENYX PHARMACEUTICAL IN
650,623$15.0M2.89%NEWCall
7
TSEMTOWER SEMICONDUCTOR LTD
122,513$14.4M2.78%-189,289
8
COGTCOGENT BIOSCIENCES INC
378,500$13.4M2.60%+280K
9
AZNASTRAZENECA PLC
135,060$12.4M2.40%
10
PRAXPRAXIS PRECISION MEDICINES I
40,000$11.8M2.28%-67,901Call
11
SNYSANOFI SA
239,515$11.6M2.24%+20K
12
LLYELI LILLY & CO
9,040$9.7M1.88%-1,000
13
AM6AMICUS THERAPEUTICS INC
658,377$9.4M1.81%-332,765
14
IMTXIMMATICS N.V
861,105$9.0M1.75%+278K
15
BMRNBIOMARIN PHARMACEUTICAL INC
147,000$8.7M1.69%NEW
16
XBISPDR SERIES TRUST
70,000$8.5M1.65%NEWPut
17
BBIOBRIDGEBIO PHARMA INC
107,746$8.2M1.59%NEW
18
ORICORIC PHARMACEUTICALS INC
1,004,378$8.2M1.59%+573K
19
DYNDYNE THERAPEUTICS INC
392,894$7.7M1.49%-33,624
20
TRVITREVI THERAPEUTICS INC
598,534$7.5M1.45%NEW
21
JNJJOHNSON & JOHNSON
35,831$7.4M1.43%-5,000
22
YB4PSAVARA INC
1,178,164$7.1M1.37%-172,169
23
SRRKSCHOLAR ROCK HLDG CORP
158,265$7.0M1.35%NEW
24
WVEWAVE LIFE SCIENCES LTD
408,166$6.9M1.34%+358K
25
HELPCYBIN INC
825,576$6.8M1.31%+455K

Quarterly Changes

New Positions

Closed Positions

Increased Positions

NameSharesChange
CLYM932K+497K
HELP826K+455K
SNDX763K+375K
IMTX861K+278K
MLYS449K+229K
ACOG568K+229K
VYGR340K+140K
CATBUSD356K+105K
ACAD212K+63K
ELVN227K+60K

Decreased Positions

NameSharesChange
ANNX1.3M-478175
TEVA1.1M-383500
AM6658K-332765
FBRX186K-288440
VTYX180K-260000
TSEM123K-189289
YB4P1.2M-172169
CATX350K-160370
JSPR485K-144069
PEPG121K-50000

Sector Breakdown

Healthcare0.0% ($3.506416672162942e+289T)
Unknown0.0% ($93757104651162959872.0T)
Technology0.0% ($15712143854200386.0T)
Financial Services0.0% ($8535409.6T)
Energy0.0% ($59.8B)
Industrials0.0% ($30.8B)

Filing History

QuarterFiling DatePortfolio ValueHoldings
Q4 2025Feb 17, 2026$517.3M100
Q3 2025Nov 14, 2025$474.1B115
Q2 2025Aug 14, 2025$426.1B111
Q1 2025May 15, 2025$434.3B116
Q4 2024Feb 14, 2025$553.1B108

Fund Information

CIK0001496201
Most Recent FilingFeb 17, 2026
Number of Filings5

SPHERA FUNDS MANAGEMENT LTD. is an institutional investment manager that files 13F reports with the SEC. As of the Q4 2025 filing, the fund reported a portfolio valued at $517.3M across 98 holdings. The largest position is TEVA PHARMACEUTICAL INDS LTD (TEVA), representing 6.8% of the portfolio. Compared to the previous quarter, the fund opened 30 new positions and closed 37 positions. 13F filings are required quarterly disclosures that provide transparency into the holdings of institutional investment managers with at least $100 million in qualifying assets.